Literature DB >> 22016823

Menin represses tumorigenesis via repressing cell proliferation.

Ting Wu, Xianxin Hua.   

Abstract

Multiple endocrine neoplasia type 1 (MEN1) results from mutations in the tumor suppressor gene, MEN1, which encodes nuclear protein menin. Menin is important for suppressing tumorigenesis in various endocrine and certain non-endocrine tissues. Although menin suppresses MEN1 through a variety of mechanisms including regulating apoptosis and DNA repair, the role of menin in regulating cell proliferation is one of the best-studied functions. Here, we focus on reviewing various mechanisms underlying menin-mediated inhibition of cell proliferation. Menin inhibits cell proliferation to repress MEN1 through multiple mechanisms. 1) Menin interacts with various histonemodifying enzymes, such as MLL, EZH2 and HDACs, to affect gene transcription, leading to repression of cell proliferation. 2) Menin also interacts with various transcription factors, such as JunD, NF-κB, PPARγ and VDR, to induce or suppress gene transcription. As these various transcription factors are known to regulate cell proliferation, their interaction with menin may be relevant to menin's role in inhibiting cell proliferation. 3) Menin inhibits cell proliferation via TGF-β signaling and Wnt/β-catenin signaling pathways. 4) Menin represses certain pro-proliferative factors involved in endocrine tumors such as IGFBP-2, IGF2 and PTHrP to repress cell proliferation. 5) Menin affects cell cycle progression to inhibit cell proliferation. This review is helpful in our understanding of the comprehensive mechanisms whereby menin represses MEN1 through inhibiting cell proliferation.

Entities:  

Keywords:  Menin; cell cycle; cell proliferation; epigenetics; gene transcription

Year:  2011        PMID: 22016823      PMCID: PMC3195934     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  103 in total

Review 1.  Signaling inputs converge on nuclear effectors in TGF-beta signaling.

Authors:  P ten Dijke; K Miyazono; C H Heldin
Journal:  Trends Biochem Sci       Date:  2000-02       Impact factor: 13.807

Review 2.  Polycomb silencers control cell fate, development and cancer.

Authors:  Anke Sparmann; Maarten van Lohuizen
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

Review 3.  In search of tumor suppressing functions of menin.

Authors:  Yuqing Yang; Xianxin Hua
Journal:  Mol Cell Endocrinol       Date:  2007-01-11       Impact factor: 4.102

4.  Menin critically links MLL proteins with LEDGF on cancer-associated target genes.

Authors:  Akihiko Yokoyama; Michael L Cleary
Journal:  Cancer Cell       Date:  2008-07-08       Impact factor: 31.743

5.  Menin-mediated caspase 8 expression in suppressing multiple endocrine neoplasia type 1.

Authors:  Ping La; Yuqing Yang; Satyajit K Karnik; Albert C Silva; Robert W Schnepp; Seung K Kim; Xianxin Hua
Journal:  J Biol Chem       Date:  2007-08-31       Impact factor: 5.157

6.  Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.

Authors:  Gao Chen; Jingbo A; Min Wang; Steven Farley; Lung-Yi Lee; Lung-Ching Lee; Mark P Sawicki
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

Review 7.  Pleiotrophin, a multifunctional tumor promoter through induction of tumor angiogenesis, remodeling of the tumor microenvironment, and activation of stromal fibroblasts.

Authors:  Pablo Perez-Pinera; Yunchao Chang; Thomas F Deuel
Journal:  Cell Cycle       Date:  2007-12-01       Impact factor: 4.534

8.  PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

Authors:  Anthony P Heaney; Manory Fernando; Shlomo Melmed
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

9.  Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs.

Authors:  Philippe Bertolino; Ivan Radovanovic; Huguette Casse; Adriano Aguzzi; Zhao-Qi Wang; Chang-Xian Zhang
Journal:  Mech Dev       Date:  2003-05       Impact factor: 1.882

10.  Nuclear-cytoplasmic shuttling of menin regulates nuclear translocation of {beta}-catenin.

Authors:  Yanan Cao; Ruixin Liu; Xiuli Jiang; Jieli Lu; Jingjing Jiang; Changxian Zhang; Xiaoying Li; Guang Ning
Journal:  Mol Cell Biol       Date:  2009-08-03       Impact factor: 4.272

View more
  14 in total

1.  Expression and subcellular localization of menin in human cancer cells.

Authors:  Feng Ren; Hong-Wei Xu; Yu Hu; Shuang-Hong Yan; Feng Wang; Bao-Wei Su; Qi Zhao
Journal:  Exp Ther Med       Date:  2012-03-29       Impact factor: 2.447

2.  Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma.

Authors:  Z Hamze; C Vercherat; A Bernigaud-Lacheretz; W Bazzi; R Bonnavion; J Lu; A Calender; C Pouponnot; P Bertolino; C Roche; R Stein; J Y Scoazec; C X Zhang; M Cordier-Bussat
Journal:  Endocr Relat Cancer       Date:  2013-10-24       Impact factor: 5.678

Review 3.  Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types.

Authors:  Sucharitha Iyer; Sunita K Agarwal
Journal:  J Mol Endocrinol       Date:  2018-04-03       Impact factor: 5.098

4.  Reduced expression of the RNA-binding protein HuD in pancreatic neuroendocrine tumors correlates with low p27Kip1 levels and poor prognosis.

Authors:  Chongtae Kim; Da Eun Jeong; Sungeun Heo; Eunbyul Ji; Jun Gi Rho; Myeongwoo Jung; Sojin Ahn; Ye-Jin Kim; Yong-Sung Kim; Suk Woo Nam; Rohit N Kulkarni; Kyoung Bun Lee; Eun Kyung Lee; Wook Kim
Journal:  J Pathol       Date:  2018-08-28       Impact factor: 7.996

Review 5.  Current understanding of the molecular biology of pancreatic neuroendocrine tumors.

Authors:  Jianliang Zhang; Rony Francois; Renuka Iyer; Mukund Seshadri; Maria Zajac-Kaye; Steven N Hochwald
Journal:  J Natl Cancer Inst       Date:  2013-07-09       Impact factor: 13.506

6.  miR-762 can negatively regulate menin in ovarian cancer.

Authors:  Rui Hou; Zhuo Yang; ShiZhuo Wang; DaMing Chu; Qifang Liu; Jia Liu; Luo Jiang
Journal:  Onco Targets Ther       Date:  2017-04-12       Impact factor: 4.147

7.  Menin Modulates Mammary Epithelial Cell Numbers in Bovine Mammary Glands Through Cyclin D1.

Authors:  Kerong Shi; Xue Liu; Honghui Li; Xueyan Lin; Zhengui Yan; Qiaoqiao Cao; Meng Zhao; Zhongjin Xu; Zhonghua Wang
Journal:  J Mammary Gland Biol Neoplasia       Date:  2017-11-29       Impact factor: 2.673

8.  Novel Mutations in Serbian MEN1 Patients: Genotype-phenotype Correlation.

Authors:  Tatjana Isailovic; Ivana Milicevic; Djuro Macut; Milan Petakov; Sanja Ognjanovic; Bojana Popovic; Ivana Bozic Antic; Tamara Bogavac; Valentina Elezovic Kovacevic; Dusan Ilic; Svetozar Damjanovic
Journal:  J Med Biochem       Date:  2019-03-01       Impact factor: 3.402

9.  Genetic and clinical features of multiple endocrine neoplasia types 1 and 2.

Authors:  C Romei; E Pardi; F Cetani; R Elisei
Journal:  J Oncol       Date:  2012-11-08       Impact factor: 4.375

10.  The Menin-Bach2 axis is critical for regulating CD4 T-cell senescence and cytokine homeostasis.

Authors:  Makoto Kuwahara; Junpei Suzuki; Soichi Tofukuji; Takeshi Yamada; Makoto Kanoh; Akira Matsumoto; Saho Maruyama; Kohei Kometani; Tomohiro Kurosaki; Osamu Ohara; Toshinori Nakayama; Masakatsu Yamashita
Journal:  Nat Commun       Date:  2014-04-02       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.